o ncology
DESCRIPTION
O ncology. Ch.9 Goodman. Cancer. Defined as a large group of diseases characterized by uncontrolled cell proliferation and the spread of abnormal cells Terms used interchangeably: n eoplasm, tumor, malignancy, carcinoma. Thoughts on Review. Does the person know they have cancer? - PowerPoint PPT PresentationTRANSCRIPT
OncologyCh.9
Goodman
Defined as a large group of diseases characterized by uncontrolled cell proliferation and the spread of abnormal cells
Terms used interchangeably:neoplasm, tumor, malignancy, carcinoma
Cancer
Does the person know they have cancer? If YES, then what implications for PT? If NO, then what next?
Thoughts on Review
Differentiation
DEFINITIONS Physical and
structural changes in cells
In CA cells, the cell loses identity from parent cell
The cell is considered to be undifferentiated or ANAPLASTIC
Less differentiation>>faster metastases
Dysplasia
More Definitions Disorganization of
cells Reversible Usually caused by
some type of irritation
Metaplasia
Hyperplasia
More definitions! Step 1 of dysplasia Cell changes from
one type to another Reversible
increased #of cells Normal alteration BUT, if it is neoplastic
hyperplasia, it is an abnormal process of tumor formation
Neoplasms These are abnormal growths that serve no
useful purpose May harm the host by: using resources,
taking up space, interfering with function of structures
Benign vs. malignant **main difference is that malignant tumors
can metastasize Primary vs. secondary primary arises from local cells Secondary have metastasized from another
part of the body
TUMORS
Classified on the basis of : cell type, tissue of origin, degree of differentiation, anatomic site and benign vs. malignant
**benign tumors can become large enough to distend, compress and obstruct normal tissue and can cause death
5 tissues of origin: epithelium, connective, nerve, lymphoid and hematopoetic
CLASSIFICATIONOF NEOPLASM
STAGING AND GRADING
Staging is more predictive Than grading
Staging is the process of describing the extent of the disease at the time of diagnosis
Aids in treatment planning
Predict clinical outcome
Compare results across treatment approaches
Grading (1-4) is another way to classify the degree of malignancy and differentiation
Lower grade cells more close to normal, more localized
Higher grade poorly differentiated cells, tend to metastasize
Systems of staging(0-4) or (TMN) 0=in situ (premalignant, preinvasive) 1=early local 2=increased risk of spread due to size 3=local has spread 4=spread and disseminated to distant sites
TMNT=tumor (0-4)N=regional lymph nodes(0-4)M=metastases 0,1 (no,yes)
Incidence, mortality and prevalence of 26 cancers available from International Agency for Research on Cancer (IARC)
Gender –based Incidence Men: prostate, lung and
bronchus,colon/rectum Women: breast, lung and bronchus,
colon/rectum
Incidence
Variable causes Divided into endogenous (genetic) and
exogenous (environmental) Multi-causal ‘webs’ are likely Carcinogen: something known to cause
cancer Approx. 500 different known carcinogens Can classify as : viral, chemical, physical
ETIOLOGY
RISK FACTORS A. 9 modifiable risk factors (responsible for
>1/3 of worldwide cancer) B. Aging- most significant risk factor for
cancer, directly proportional to risk C. Lifestyle
PATHOGENESIS
Somatic mutation theory Current theory of Oncogenesis
◦ Oncogenes◦ Antioncogenes
Tumor biochemistry and pathogenesis
Seed vs. soil theory: cancer cell (seed) has to find the right microenvironment (soil)
Incidence of metastasis: approx. 30% of people with newly diagnosed cancer have detectable metastases
Approx. 30-40% have hidden metastases Mechanism of metastasis: lymph>>blood
stream
INVASION AND METASTASIS5 common sites: lymph nodes, liver, lung, bone, brain
Lung (pulmonary) Liver (hepatic) Bone (skeletal) Brain and spinal cord (CNS) Lymph nodes (lymphatic)
CLINICAL MANIFESTATIONS OF METASTASIS
Depends on whether the cellular structure is similar enough to the primary growth
If unable, then the malignant tissue is called “carcinoma of unknown primary”
DIAGNOSIS OF METASTASIS
Disease free survival= time between diagnosis and recurrence or relapse
Recurrences may be local, regional, disseminated
Predictors of recurrence: stage at time of initial therapy and histological findings
Recurrence can be recognized by:◦ Return of systemic symptoms◦ Metabolic or toxic effects of the disease
(hyponatremia, hypercalcemia)
CANCER RECURRENCE
Local and Systemic◦ Most cancers are asymptomatic at first and have
to advance before showing signs and symptoms◦ With progression, symptoms and signs of the
involved tissue can appear◦ Advanced malignant cancer and its treatment can
lead to nausea, vomiting and retching (NVR) accompanied by anorexia and weight loss
CLINICAL MANIFESTATIONS
Most common symptom of cancer 50-70% in early stages, 60-90% in late
stages Pain >depression/anxiety>pain>>>>> >>>depression/anxiety>increased pain Some patients have a fear of tolerance or
meds, fear of addiction, fear of side effects and can lead to underreporting of pain> pain induced loss of function
CANCER PAIN
Multifaceted 1. nerve impingement 2. interference of blood supply to nerves 3. bone metastases>mild to intense bone
pain; pathological fractures>subsequent pain; muscle spasm
4. diagnostic or therapeutic procedures (surgery, radiation, chemotherapy)
5. inflammation can progress to infection, necrosis
ETIOLOGY AND PATHOGENESIS
How will the body react to pain?
1. signs of mild-moderate superficial pain>increased sympathetic nervous system involvement◦ Hypertension, tachycardia, tachypnea
2. Signs of severe or visceral pain> increased parasympathetic nervous system involvement◦ Hypotension, bradycardia, nausea, vomiting, weakness,
fainting
CLINICAL MANIFESTATIONS OF PAIN
*May depend on underlying etiology *Also depends on pain being acute or
chronic *IF acute: gain control and sustain *Prior to pain therapy, physician determines
underlying mechanism and diagnoses the pain syndrome
*Approach: treat the cause as much as possible; treat the effect when needed◦ Example: radiation/chemo treat the CAUSE◦ Example: narcotics treat the EFFECT
PAIN CONTROL
Based on client preference and clinical judgment Can reduce procedural pain and distress Examples: cryotherapy, thermotherapy, electrical
stimulation, immobilization, exercise, massage, biofeedback and relaxation techniques
*direct pressure over a tumor is discouraged; although no evidence that massage can spread cancer
*Neuropathic pain is difficult as traditional analgesics don’t always work; options include infrared, anti-depressants, antiepileptics, steroids
NON PHARMACOLOGICAL APPROACHES TO PAIN CONTROL
CRF syndrome is a collection of symptoms with multiple characteristics/problems
Fatigue is nearly universal in people receiving chemotherapy and radiation
Up to 30% of survivors report loss of energy for years after treatment
Reassurance that treatment related fatigue is not necessarily an indicator of disease progression
fatigue is a symptom and attempts to identify causes may lead to identifying whether or not it can be classified as CRF
CANCER RELATED FATIGUE (CRF)
In addition to local effects of tumor growth, cancer can produce systemic signs and symptoms that are indirect effects of the tumor
Etiology not well understood Clinical manifestations: important as they may provide an early
clue to the presence of cancer Non-specific symptoms: neurological changes, anorexia,
malaise, diarrhea, weight loss and fever may be the first clinical manifestations
Musculoskeletal manifestations include weakness from proximal>distal (common with small cell lung CA) and similar to weakness pattern of people taking prednisone (corticosteroid)
Medical management: serodiagnostics, MRI, biochemical markers may identify syndromes BUT finding the underlying malignancy is crucial for successful resolution
PARANEOPLASTIC SYNDROME
Prevention! Primary prevention: screening,
chemoprevention (agents used to inhibit and reverse cancer)> focus has been on diet derived agents (green and black tea phenols), cancer vaccine research (vaccines against viruses), using person’s own tumor cells which are radiated to inactivate and reinfused to build antibodies
MEDICAL MANAGEMENT
Secondary prevention: preventing morbidity and mortality via early detection and treatment
Tertiary prevention: managing symptoms, limiting complications, preventing disability
More prevention
1. Medical history/exam 2. lab values 3. radiography 4. endoscopy 5. isotope scan 6. CT scan 7. mammography 8. MRI 9. biopsy 10. tumor markers
DIAGNOSIS
Curative: surgery, XRT, chemotherapy, biotherapy (immunotherapy), hormonal
INTENT TO CURE
Palliative: radiation, chemotherapy, physical therapy, alternative medicine, naturopathic, hospice
SYMPTOM RELIEF
TREATMENT
New movement of combining alternative medicine with mainstream conventional therapies
Curative vs. palliative More evidence for palliative
COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM)
1. Surgery 2. Radiation therapy (RT, XRT): can be internal
(brachytherapy) or external (beam) 3. Chemotherapy: chemical agents to destroy cancer
cells (widespread) 4. Biotherapy: still experimental ; use of biologic
response modifiers (BRMs) to strengthen the response against tumor cells
5. Antiangiogenic therapy: stops pathologic angiogenesis (can kill tumor cells and stop /reduce metastases)
6. Hormonal therapy: beneficial if cancer cells rely on hormones (breast cancer thrives with estrogen)
MAJOR MEDICAL TREATMENTS
Moderate habitual exercise is a potentially protective measure against certain types of cancer
Exercise for the person with cancer: LOTS to think about!
1. Seems to have a beneficial influence on clinical course
2. Do a Screening and assessment◦ Caution regarding fatigue and pain◦ Recent labs helpful◦ Chemotherapy can lead to cardiac dysfunction years
after treatment
CANCER, PHYSICAL ACTIVITY AND EXERCISE TRAINING
3. Monitoring vitals; depending on variations in response, may use THR and/or RPE and monitor responses relative to absolute demands
4. Exercise during and after chemotherapy 5. Exercise for cancer-related fatigue 6. Prescriptive exercise 7. Exercise and lymphedema 8. Exercise and advanced cancer 9. Exercise for cancer survivors
EXERCISE GUIDLEINES (continued)
A. Incidence and Overview: * 8400 children in US diagnosed each year * 2000 deaths in US (<19 years old)
attributed to cancer B. Types of Childhood Cancer *Most common: acute lymphocytic leukemia
(ALL), lymphomas, brain tumors, embryonal (ovary, testicular) tumors and soft tissue sarcomas
CHILDHOOD CANCER
**Advances have greatly improved prognosis; however with increased survival rates, there is growing concern of late effects (damaging effects of surgery, radiation, chemo as well as social, emotional, economic effects)
*Late effects can include CNS deficits: intelligence, hearing, vision, endocrine abnormalities such as short stature or hypothyroidism, or delayed secondary sexual development
LATE EFFECTS AND PROGNOSIS
*The role of the physical therapist in the care of a cancer patient :
May be involved in all phases of care: prevention, restoration, support and palliative care
Physical therapists can be involved in the early stages of cancer treatment to assist with: weakness, inflexibility, risk of falls, altered breathing patterns, lymphedema, fatigue and psychosocial issues
PHYSICAL THERAPIST IMPLICATIONS
Assisting with management of side effects of treatment
Accomodations and/or assistive devices Physical agents/modalities Sexual issues QOL!
OTHER WAYS WE CAN HELP
uscnorriscancerhospital dukehealth.org vetmed.ucdavis.edu tdi-dog.org classroomdogs.wikispaces
Resources
Andrea C. Mendes PT, DPT in collaboration with Sean M. Collins PT, ScD
Created by